drugset
drugset / Trial / NCT03419364

Study of Nicotinamide in Early Onset Preeclampsia

NCT03419364 ↗

Phase 2 Completed 23 enrolled University of North Carolina, Chapel Hill Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Phase II Study of 2.5 gm of nicotinamide, given daily in 3 divided doses, to measure effect on maternal blood pressure in women with early onset preeclampsia and to determine peak and trough levels of nicotinamide. We will compare peak and trough levels in healthy non-pregnant and healthy pregnant participants.

Timeline

Start
2017-11-01
Primary completion
2021-08-31
Completion
2021-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotinamide Other / unclassified 2.5 g Oral

Indications

preeclampsia